Global Transplant Diagnostics Market Overview:
Global Transplant Diagnostics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Transplant Diagnostics Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Transplant Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Transplant Diagnostics Market:
The Transplant Diagnostics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Transplant Diagnostics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Transplant Diagnostics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Transplant Diagnostics market has been segmented into:
Molecular Assays
Non-Molecular Assays
By Application, Transplant Diagnostics market has been segmented into:
Instruments
Reagent & Consumables
Software & Services).
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Transplant Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Transplant Diagnostics market.
Top Key Players Covered in Transplant Diagnostics market are:
Becton
Dickinson and Company
Biofortuna Ltd.
bioMerieux SA
Bio-Rad Laboratories Inc.
CareDx Inc.
F. Hoffmann-La Roche AG
GenDx
Hologic Inc.
Illumina Inc.
Immucor Inc.
Luminex Corporation
Merck KgaA
Omixon
Qiagen NV
Thermo Fisher Scientific Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Transplant Diagnostics Market Type
4.1 Transplant Diagnostics Market Snapshot and Growth Engine
4.2 Transplant Diagnostics Market Overview
4.3 Molecular Assays
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Molecular Assays: Geographic Segmentation Analysis
4.4 Non-Molecular Assays
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Non-Molecular Assays: Geographic Segmentation Analysis
Chapter 5: Transplant Diagnostics Market Application
5.1 Transplant Diagnostics Market Snapshot and Growth Engine
5.2 Transplant Diagnostics Market Overview
5.3 Instruments
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Instruments: Geographic Segmentation Analysis
5.4 Reagent & Consumables
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Reagent & Consumables: Geographic Segmentation Analysis
5.5 Software & Services).
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Software & Services).: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Transplant Diagnostics Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BECTON
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 DICKINSON AND COMPANY; BIOFORTUNA LTD.; BIOMERIEUX SA; BIO-RAD LABORATORIES
6.4 INC.; CAREDX
6.5 INC.; F. HOFFMANN-LA ROCHE AG; GENDX; HOLOGIC
6.6 INC.; ILLUMINA
6.7 INC.; IMMUCOR
6.8 INC.; LUMINEX CORPORATION; MERCK KGAA; OMIXON; QIAGEN NV; THERMO FISHER SCIENTIFIC
6.9 INC.
Chapter 7: Global Transplant Diagnostics Market By Region
7.1 Overview
7.2. North America Transplant Diagnostics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Molecular Assays
7.2.2.2 Non-Molecular Assays
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Instruments
7.2.3.2 Reagent & Consumables
7.2.3.3 Software & Services).
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Transplant Diagnostics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Molecular Assays
7.3.2.2 Non-Molecular Assays
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Instruments
7.3.3.2 Reagent & Consumables
7.3.3.3 Software & Services).
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Transplant Diagnostics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Molecular Assays
7.4.2.2 Non-Molecular Assays
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Instruments
7.4.3.2 Reagent & Consumables
7.4.3.3 Software & Services).
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Transplant Diagnostics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Molecular Assays
7.5.2.2 Non-Molecular Assays
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Instruments
7.5.3.2 Reagent & Consumables
7.5.3.3 Software & Services).
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Transplant Diagnostics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Molecular Assays
7.6.2.2 Non-Molecular Assays
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Instruments
7.6.3.2 Reagent & Consumables
7.6.3.3 Software & Services).
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Transplant Diagnostics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Molecular Assays
7.7.2.2 Non-Molecular Assays
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Instruments
7.7.3.2 Reagent & Consumables
7.7.3.3 Software & Services).
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Transplant Diagnostics Scope:
|
Report Data
|
Transplant Diagnostics Market
|
|
Transplant Diagnostics Market Size in 2025
|
USD XX million
|
|
Transplant Diagnostics CAGR 2025 - 2032
|
XX%
|
|
Transplant Diagnostics Base Year
|
2024
|
|
Transplant Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Becton, Dickinson and Company, Biofortuna Ltd., bioMerieux SA, Bio-Rad Laboratories Inc., CareDx Inc., F. Hoffmann-La Roche AG, GenDx, Hologic Inc., Illumina Inc., Immucor Inc., Luminex Corporation, Merck KgaA, Omixon, Qiagen NV, Thermo Fisher Scientific Inc..
|
|
Key Segments
|
By Type
Molecular Assays
Non-Molecular Assays
By Applications
Instruments
Reagent & Consumables
Software & Services).
|
